
ECHA Evaluates Regulatory Needs for Hydroxyphenyl Benzotriazoles
If the hazards are confirmed, restrictions on the use of these substances are proposed to minimise environmental release and human exposure.
Search and browse our complete archive of chemical regulatory news.
Showing 20 articles on page 29 of 41

If the hazards are confirmed, restrictions on the use of these substances are proposed to minimise environmental release and human exposure.

The evaluation confirms that Diuron poses a confirmed risk of endocrine disruption to the environment.

Tests revealed that a children's jewellery set contained over 6,000 times the legal limit of Cadmium, a carcinogenic element.

This case highlights the ongoing debates and disagreements between chemical companies and regulatory authorities over the safety classifications of substances.

The law will roll out in phases: key sections on chemicals in cosmetics, menstrual products, PFAS, and firefighting agents take effect January 1, 2026.

The Court found that CFE's appeal did not meet the necessary criteria to proceed.

Several silver compounds have been identified as potential reproductive toxins.

The EPA has conducted an economic analysis estimating the incremental costs of the proposed rule to be approximately $396 million annually over 20 years.

The law outlines a phased approach to banning products containing intentionally added PFAS, with specific dates for different categories.

The board concluded that Jungbunzlauer Ladenburg GmbH's registration dossier remained non-compliant with the necessary information requirements.

A significant 81% of participants recognised the presence of "free riders" who avoid compliance duties.

ECHA finds existing regulations address EDC risks in articles, so no new restrictions are needed. Continued monitoring and enforcement are essential.

ECHA's new consultation process ensures thorough assessment of hazardous substances, aiming to identify and utilise safer alternatives whenever possible.

The Commission has opened a public consultation period ending on 27 June 2024.

The new regulation sets up a structured program for the gradual review of safeners and synergists already on the market.

In May 2023, the EPA reviewed two suspicious studies conducted at Palamur, leading to concerns about possible data falsification.

The Clean Air Act mandates that facilities using extremely hazardous substances must develop and implement risk management plans.

From 6 June 2026, D4, D5, and D6 cannot be marketed as substances, constituents, or in mixtures with concentrations ≥0.1% by weight, with certain exemptions.

France and Germany cited health risks from manufacturing and harmful substances, including isocyanates and PBT/vPvB chemicals, in the biocidal product.

Stakeholders with info on PFAS or alternatives in firefighting foams, especially in GB, are urged to engage in further dialogue with the Agency.
Subscribe to Foresight Weekly and get the latest insights on regulatory changes affecting chemical compliance.
Free forever. Unsubscribe anytime.
Read by professionals at